Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
2.700
+0.010 (0.37%)
At close: Apr 28, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Ovid Therapeutics Market Cap
Ovid Therapeutics has a market cap or net worth of $467.2 million as of April 28, 2026. Its market cap has increased by 2,481.22% in one year.
Market Cap
467.20M
Enterprise Value
390.17M
1-Year Change
2,481.22%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since May 5, 2017, Ovid Therapeutics's market cap has increased from $301.40M to $467.20M, an increase of 55.01%. That is a compound annual growth rate of 5.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 354.70M | 205.51% |
| Dec 31, 2025 | 116.10M | 75.11% |
| Dec 31, 2024 | 66.30M | -70.87% |
| Dec 29, 2023 | 227.60M | 73.61% |
| Dec 30, 2022 | 131.10M | -40.03% |
| Dec 31, 2021 | 218.60M | 49.22% |
| Dec 31, 2020 | 146.50M | -26.16% |
| Dec 31, 2019 | 198.40M | 232.33% |
| Dec 31, 2018 | 59.70M | -75.41% |
| Dec 29, 2017 | 242.80M | -19.44% |
| May 5, 2017 | 301.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 478.27M |
| Valneva SE | 470.89M |
| Candel Therapeutics | 468.78M |
| Entrada Therapeutics | 467.64M |
| Climb Bio | 466.22M |
| Prelude Therapeutics | 462.54M |
| Aura Biosciences | 461.60M |
| Larimar Therapeutics | 460.20M |